Chronic cannabis use was associated with reduced attention-related brain responses in healthy people but not in people with schizophrenia, suggesting the two groups may have fundamentally different endocannabinoid systems.
Read this if you want to understand how cannabis affects the brain differently in people with and without schizophrenia.
Cannabis-related attention deficits correlated with use duration in healthy users (r = -0.57) but not in schizophrenia patients.
What the researchers found
Researchers measured attention-related brainwave responses (P300) in four groups: schizophrenia patients with and without chronic cannabis use, and healthy controls with and without chronic cannabis use. All cannabis users had been abstinent for at least 28 days.
As expected, schizophrenia patients overall showed reduced P300 responses. But the cannabis effect was unexpected: chronic cannabis use was associated with reduced P300 responses in the healthy control group, but not in the schizophrenia group.
In healthy cannabis users, the P300 reduction correlated with both the amount and duration of cannabis use. In schizophrenia patients who used cannabis, no such correlation existed. The P300 differences between cannabis users and non-users in the healthy group were statistically significant, while the schizophrenia group showed no significant difference.
Why it matters
The finding that cannabis affects attention differently in people with and without schizophrenia has a provocative implication: it suggests the endocannabinoid system may already be altered in schizophrenia, making it less responsive to additional cannabinoid insult. This aligns with theories that endocannabinoid dysfunction is part of schizophrenia's underlying biology.
The numbers in context
80 participants in 4 groups of 20. Mean cannabis use: 8.3 years (schizophrenia group), 9.1 years (controls). Minimum 28 days abstinent. Healthy cannabis users showed dose-dependent left-hemispheric P300 reduction (r = -0.50 for amount, r = -0.57 for duration).
How the study worked
The study used auditory novelty and oddball P300 evoked potential paradigms in 80 participants divided into four groups of 20: schizophrenia with chronic cannabis use (abstinent 28+ days), schizophrenia without, healthy controls with chronic cannabis use (abstinent 28+ days), and healthy controls without. Mean duration of regular cannabis use was 8.3 years (schizophrenia group) and 9.1 years (control group).
What this study cannot tell us
Cross-sectional design cannot establish causation. The 28-day abstinence requirement may not fully eliminate residual cannabis effects. The study included both first-episode and chronic schizophrenia patients, mixing different illness stages. The sample size (20 per group) limits statistical power.
How to read the evidence
Moderate evidence from a well-controlled neurophysiology study with appropriate comparison groups, though limited by sample size and cross-sectional design.
When this study was published
Published in 2016. The endocannabinoid dysfunction hypothesis in schizophrenia continues to be investigated.
The bigger picture
The relationship between cannabis and schizophrenia is often framed as cannabis causing psychosis. This study adds nuance by showing that cannabis affects the brains of people with schizophrenia differently than healthy brains, suggesting pre-existing neurobiological differences that may influence both vulnerability to psychosis and response to cannabis.
Questions still open
- Is the endocannabinoid system already dysfunctional in schizophrenia, making cannabis effects different? Do the attention deficits in healthy cannabis users resolve with longer abstinence? Could P300 measurements be used to identify cannabis-related cognitive risk?
Common questions
Does cannabis affect the brain the same way in everyone?
Does this mean cannabis is safer for people with schizophrenia?
Read the original research
Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.
European archives of psychiatry and clinical neuroscience, 266(5), 409-21
Citation
Rentzsch, Johannes; Stadtmann, Ada; Montag, Christiane; Kunte, Hagen; Plöckl, Doris; Hellweg, Rainer; Gallinat, Jürgen; Kronenberg, Golo; Jockers-Scherübl, Maria Christiane. (2016). Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.. European archives of psychiatry and clinical neuroscience, 266(5), 409-21. https://doi.org/10.1007/s00406-015-0616-y
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)